AzTrials
AzTrials

Caregivers of Alzheimer's Disease or Memory Problem PatientsWECARENCT07429591

Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia

A study testing Risk Assessment Screening and Coach and Website Intervention in people with Caregivers of Alzheimer's Disease or Memory Problem Patients and Caregiver Wellbeing, run by University of Southern California at 1 site in United States.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test a risk assessment screening and intervention for caregivers of people with dementia. The main questions it aims to answer are: 1. What are the harms and benefits of administering the elder abuse risk assessment screening? 2. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Risk Assessment Screening and Coach and Website Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000 participants
Where
1 siteUnited States
Study dates
1 May 2026to 30 Aug 2027
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years old or older
  • Speak English or Spanish
  • Caregiver for a person with Alzheimer's Disease or another type of dementia
  • Provide substantial care for this person, defined as assisting with at least one activity of daily living or two instrumental activities of daily living
  • See this person at least twice a week
  • Have access to the internet

Who cannot join

  • Under 18 years old
  • Speak language besides English or Spanish
  • Caregiver for person who does not have dementia
  • Do not provide substantial care for this person
  • Primary relationship between caregiver and person with dementia is that of a professional paid caregiver
  • Enrolled in another caregiver study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Keck Medicine

    Los Angeles, California, 90003

Other trials in United States

About this study

The goal of this clinical trial is to test a risk assessment screening and intervention for caregivers of people with dementia. The main questions it aims to answer are:

  1. What are the harms and benefits of administering the elder abuse risk assessment screening?
  2. What are the harms and benefits of administering the caregiver intervention?
Read more

Researchers will compare participants who receive the screening and caregiver intervention to a group who does not receive the caregiver intervention and a group who receives neither the screening or the caregiver intervention to answer these questions.

Participants will:

  • Complete two surveys, three months apart
  • Complete a 5-item screening tool, if assigned to one of the screening groups
  • Complete a 3-session caregiver intervention, if assigned to that group
Read the detailed description

This study aims to address the issue of elder mistreatment which affects one in ten older adults, and is particularly prevalent among those with dementia, where rates can reach 50%. In this randomized study, caregivers are assigned to different study groups so researchers can evaluate outcomes across varying levels of support. The project examines how structured assessment and caregiver-focused education influence caregiver stress, decision-making, and overall care dynamics, with the broader aim of informing scalable prevention strategies within primary care systems

Being tested
Risk Assessment Screening, Coach and Website Intervention
Keywords
elder mistreatment, caregiver wellness, Dementia care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Risk Assessment ScreeningBehavioural

    A five question tool that can be delivered verbally or through written self-administration.

  • Coach and Website InterventionBehavioural

    A three-session community health worker intervention, including a caregiver information website.

Study groups in NCT07429591
Study groupRoleWhat they receive
ControlNo interventionParticipants will receive no intervention, only the two study surveys.
Risk Assessment Screening OnlyExperimentalParticipants will complete the risk assessment screening along with the two study surveys.
Receives: Behavioral: Risk Assessment Screening
Risk Assessment Screening and Coach InterventionExperimentalParticipants will complete the risk assessment screening, three coach sessions, intervention website, and the two study surveys.
Receives: Behavioral: Risk Assessment Screening; Behavioral: Coach and Website Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caregiver Depression Symptoms

    Measured through Patient Health Questionnaire-8 score (0-24) .

    Measured: Enrollment to three months

  2. Caregiver Anxiety Symptoms

    Measured by Generalized Anxiety Disorder-7 screening tool score (0-21) .

    Measured: Enrollment to three months

  3. Caregiver Burden

    Measured by Zarit Burden Interview-6 scores (6-24)

    Measured: Enrollment to three months

  4. Caregiver Stress About Care Receiver Behavioral Symptoms

    Measured by Neuropsychiatric Inventory Questionnaire scores (0-60)

    Measured: Enrollment to three months

Secondary outcomes (13)
  1. Elder Mistreatment

    Measured using combined and modified Geriatric Mistreatment Scale and Older Adult Conflict Scale (0-19)

    Measured: Enrollment to three months

  2. Healthcare Use of Person Living with Demenita

    Count of each emergency department, hospitalization, and outpatient medical visits.

    Measured: Enrollment to three months

  3. Dementia Knowledge

    Measured using Dementia Attitudes Scale scores (0-36)

    Measured: Enrollment to three months

  4. Caregiver Self Efficacy

    Measured using Self-Efficacy for Caregiving scores (8-40)

    Measured: Enrollment to three months

  5. Resilience

    Measured using modified Brief Resilience Scale scores (6-24)

    Measured: Enrollment to three months

  6. Elder Abuse Knowledge

    Measured using survey questions from previous UK study, with summary scores ranging from 15 to 75 (higher numbers indicating higher understanding of elder abuse).

    Measured: Enrollment to three months

  7. Stress

    Measured using the Perceived Stress Scale scores (0-40)

    Measured: Enrollment to three months

  8. Emotional Regulation

    Measured using modified Difficulties in Emotion Regulation Scale (4-16)

    Measured: Enrollment to three months

  9. Anger

    Measured using the Dimensions of Anger Reactions scale (5-25)

    Measured: Enrollment to three months

  10. Hopelessness

    Measured using modified Beck Hopelessness Inventory scores (7-28)

    Measured: Enrollment to three months

  11. Social Support

    Measured using Duke/UNC Functional Social Support Questionnaire scores (8-40)

    Measured: Enrollment to three months

  12. Coping

    Measured using count of adaptive (0-18) and maladaptive (0-4) coping methods on novel measure

    Measured: Enrollment to three months

  13. Positive Aspects of Caregiving

    Measured using Positive Aspects of Caregiving Scale scores (6-24)

    Measured: Enrollment to three months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2026
  2. Study start1 May 2026 (estimated)
  3. Primary completion1 Jun 2027 (estimated)
  4. Study completion30 Aug 2027 (estimated)

Why it stopped: Study paused per IRB request.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07429591
Sponsor's protocol ID
R33AG078475
Other IDs
4R33AG078475-03
Acronym
WECARE
Status last verified
Feb 2026
First submitted
4 Feb 2026
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Risk Assessment Screening and Coach and Website Intervention in people with Caregivers of Alzheimer's Disease or Memory Problem Patients and Caregiver Wellbeing, run by University of Southern California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caregiver Depression Symptoms (time frame: Enrollment to three months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in